Drawing for MEASURE. MANAGE. LEAD.

USPTO serial 90308412

MEASURE. MANAGE. LEAD.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COLEMAN, CIMMERIAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEASURE. MANAGE. LEAD.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

Jessica L. Rothstein GOODWIN PROCTER LLP620 EIGHTH AVENUENEW YORK, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Healthcare industry business consulting and advisory services; business management consultation and advisory services, namely, business intelligence, business prediction, business analytics, web analytics and business performance management services; business management consultation and advisory services in the fields of productivity, revenue, profitability, market analysis, marketing; business management consultation and advisory services relating to revenue cycle management; business management consulting and advisory services relating to revenue growth, assessment of revenue growth opportunities, and development and execution of revenue growth plans; business consulting services, namely, data collection, aggregation, analysis and rating of business markets and business benchmarking services in connection with financial operations in the health care industry; analyzing and compiling data for measuring clinical performance for business forecasting and analysis; business risk management services, namely, risk segmentation analysis for the health care industryACTIVE—
036Financial risk management services, namely, providing information and data in the field of credit and financial information; financial risk management services, namely, risk segmentation analysis for the health care industry; financial risk management consultation, namely, providing risk benchmarking; providing information and advice in the field of credit and financial informationACTIVE—
042Computer, information technology, and application service provider services, namely, hosting computer software applications for use by others for business planning, monitoring, analysis, web analytics, management and productivity; computer and information technology services, namely, acting as an application service provider by hosting computer application software for creating searchable databases of information and data in the fields of financial, accounting, enterprise management information, business analytics and business management analytics; acting as an application service provider in the field of knowledge management to host computer application software for searching and retrieving information from databases and computer networks; information technology consultation services for use in risk management and regulatory compliance by hospital systems, third-party payors, professionals, and management in the healthcare fieldACTIVE—
045Reviewing standards and practices to assure compliance with healthcare and fair credit reporting-related laws and regulations; and regulatory compliance consultation in the field of healthcare and fair credit reporting-related laws and regulationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 25, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 25, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 22, 2021EXT1SOU EXTENSION 1 FILED—
Dec 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2021DOCKASSIGNED TO EXAMINER—
Jan 9, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance